Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome.
200 publications have been identified in PubMed for FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome. Kisho has analyzed 149 by research type. Research spans Basic Science / Preclinical (55%), Review / Meta-Analysis (27%), and Case Report / Case Series (7%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 82 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:44 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome
Research summaries | 40 | 27% |
Patient case studies | 11 | 7% |
New treatment approaches | 9 | 6% |
Disease patterns and progression | 5 | 3% |
Testing and diagnosis research | 2 | 1% |
Kennedy JT (2026). [PMID: 41549404](https://pubmed.ncbi.nlm.nih.gov/41549404/). *Alzheimers Dement*. [Epidemiology / Natural History]
Kiral FR (2026). [PMID: 41475351](https://pubmed.ncbi.nlm.nih.gov/41475351/). *Cell Stem Cell*. [Basic Science / Preclinical]
Gomez-Andres D (2026). [PMID: 41896003](https://pubmed.ncbi.nlm.nih.gov/41896003/). *Handb Clin Neurol*. [Review / Meta-Analysis]
Mancini V (2026). [PMID: 40623620](https://pubmed.ncbi.nlm.nih.gov/40623620/). *Biol Psychiatry*. [Review / Meta-Analysis]
Liu J (2026). [PMID: 41729367](https://pubmed.ncbi.nlm.nih.gov/41729367/). *Cell Biol Toxicol*. [Review / Meta-Analysis]
Lattke M (2026). [PMID: 41545595](https://pubmed.ncbi.nlm.nih.gov/41545595/). *Nat Med*. [Basic Science / Preclinical]
Mahdi J (2026). [PMID: 41053233](https://pubmed.ncbi.nlm.nih.gov/41053233/). *Nat Rev Immunol*. [Review / Meta-Analysis]
He R (2026). [PMID: 41165761](https://pubmed.ncbi.nlm.nih.gov/41165761/). *J Clin Invest*. [Basic Science / Preclinical]
Handen BL (2025). [PMID: 40371686](https://pubmed.ncbi.nlm.nih.gov/40371686/). *Alzheimers Dement*. [Diagnostic / Biomarker]
Asadollahi R (2025). [PMID: 41125872](https://pubmed.ncbi.nlm.nih.gov/41125872/). *Nat Genet*. [Basic Science / Preclinical]